A case of malignant insulinoma responsive to somatostatin analogs treatment

被引:0
作者
Mariasmeralda Caliri
Valentina Verdiani
Edoardo Mannucci
Vittorio Briganti
Luca Landoni
Alessandro Esposito
Giulia Burato
Carlo Maria Rotella
Massimo Mannelli
Alessandro Peri
机构
[1] University of Florence,Endocrine Unit, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”
[2] Careggi University Hospital,Diabetology Unit, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”
[3] University of Florence,Division of Nuclear Medicine
[4] Careggi University Hospital,General and Pancreatic Surgery Department
[5] Careggi University Hospital,Department of Pathology and Diagnostics
[6] The Pancreas Institute-University of Verona Hospital Trust,undefined
[7] University of Verona Hospital Trust,undefined
来源
BMC Endocrine Disorders | / 18卷
关键词
Insulinoma; Hypoglycemia; Somatostatin analogs; Octreotide;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects
    Mazziotti, Gherardo
    Mosca, Alessandra
    Frara, Stefano
    Vitale, Giovanni
    Giustina, Andrea
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (16) : 1679 - 1689
  • [22] Treatment of pancreatic cancerPromises and problems of tamoxifen, somatostatin analogs, and gemcitabine
    Lawrence Rosenberg
    International journal of pancreatology, 1997, 22 (2) : 81 - 93
  • [23] A case of malignant insulinoma: successful control of glycemic fluctuation by replacing octreotide injections with octreotide LAR injections
    Okamoto, Masahide
    Kishimoto, Miyako
    Takahashi, Yoshihiko
    Osame, Keiichiro
    Noto, Hiroshi
    Yamamoto-Honda, Ritsuko
    Kajio, Hiroshi
    Tokuhara, Makoto
    Edamoto, Yoshihiro
    Endo, Hisako
    Igari, Toru
    Kubota, Kazuo
    Noda, Mitsuhiko
    ENDOCRINE JOURNAL, 2013, 60 (08) : 951 - 957
  • [24] Somatostatin analogs in the treatment of medullary thyroid carcinoma
    J. J. Díez
    P. Iglesias
    Journal of Endocrinological Investigation, 2002, 25 : 773 - 778
  • [25] Somatostatin analogs in the treatment of medullary thyroid carcinoma
    Díez, JJ
    Iglesias, P
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (09) : 773 - 778
  • [26] Somatostatin analogs for cancer treatment and diagnosis: An overview
    Scarpignato, C
    Pelosini, I
    CHEMOTHERAPY, 2001, 47 : 1 - 29
  • [27] A non-secretory malignant insulinoma: a case report
    Zarei, Mohammad
    Dastras, Majid
    Roshanravan, Mostafa
    BIOMEDICAL RESEARCH AND THERAPY, 2019, 6 (03): : 3093 - 3095
  • [28] A Rare Case of Malignant Insulinoma Associated With Gastrointestinal Bleed
    Boateng, William K.
    Ezeh, Kosisochukwu J.
    Botros, Youssef
    Spira, Etan
    Shen, Tingliang
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [29] Preoperative detection of functional somatostatin receptors in a patient with an insulinoma
    Oguni, Kohei
    Fukushima, Shinnosuke
    Yamamoto, Yukichika
    Hasegawa, Kou
    Hagiya, Hideharu
    Inoshita, Naoko
    Otsuka, Fumio
    CLINICAL CASE REPORTS, 2023, 11 (08):
  • [30] Treatment of pancreatic cancer - Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine
    Rosenberg, L
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 1997, 22 (02) : 81 - 93